Hypertensive Heart Failure in Asia

Helsi Rismiati1, Hae-Young Lee1

  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

Insights

Effective blood pressure control is crucial for preventing and managing hypertensive heart failure (HHF), particularly in Asian populations where it is a leading cause of heart failure. Managing hypertension is key to reversing cardiac dysfunction.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Heart Failure Studies

Background:

  • Hypertension (HT) is a significant risk factor for heart failure (HF).
  • The prevalence of HT-related HF is notably higher in Asia, where it is a primary cause of HF.
  • Hypertensive heart failure (HHF) arises from cardiac structural and functional changes, including left ventricular hypertrophy (LVH).

Purpose of the Study:

  • To review the epidemiology, pathophysiology, outcomes, and blood pressure (BP) management implications for HHF.
  • To focus specifically on the Asian population, given the higher prevalence of HHF in this region.

Main Methods:

  • Literature review focusing on hypertensive heart failure.
  • Analysis of epidemiological data, pathophysiological mechanisms, and clinical outcomes.
  • Examination of the role of blood pressure management in HHF.

Main Results:

  • Hypertensive LVH contributes to diastolic dysfunction and increases risk for myocardial infarction, leading to systolic dysfunction.
  • Asymptomatic LV dysfunction can progress to overt HF.
  • Effective BP control can reverse HHF, highlighting its importance in primary and secondary HF prevention.

Conclusions:

  • Hypertension control is essential for both preventing and treating hypertensive heart failure.
  • Understanding HHF in the Asian population is critical due to regional prevalence.
  • Further research into HHF pathophysiology and management strategies is warranted.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
109
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
92
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
551
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
65
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
40